234 related articles for article (PubMed ID: 7560615)
1. Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. The TIMI Investigators.
Mueller HS; Forman SA; Menegus MA; Cohen LS; Knatterud GL; Braunwald E
J Am Coll Cardiol; 1995 Oct; 26(4):900-7. PubMed ID: 7560615
[TBL] [Abstract][Full Text] [Related]
2. Predictors of nonfatal reinfarction in survivors of myocardial infarction after thrombolysis. Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) Data Base.
Volpi A; de Vita C; Franzosi MG; Geraci E; Maggioni AP; Mauri F; Negri E; Sontoro E; Tavazzi L; Tognoni G
J Am Coll Cardiol; 1994 Sep; 24(3):608-15. PubMed ID: 8077528
[TBL] [Abstract][Full Text] [Related]
3. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
[TBL] [Abstract][Full Text] [Related]
4. Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II).
Ruocco NA; Bergelson BA; Jacobs AK; Frederick MM; Faxon DP; Ryan TJ
J Am Coll Cardiol; 1992 Dec; 20(7):1445-51. PubMed ID: 1452916
[TBL] [Abstract][Full Text] [Related]
5. Prospective validation of a composite end point in thrombolytic trials of acute myocardial infarction (TIMI 4 and 5). Thrombosis In Myocardial Infarction.
Cannon CP; Sharis PJ; Schweiger MJ; McCabe CH; Diver DJ; Shah PK; Sequeira RF; Greene RM; Perritt RL; Poole WK; Braunwald E
Am J Cardiol; 1997 Sep; 80(6):696-9. PubMed ID: 9315571
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of nonfatal myocardial reinfarction. Multicenter Diltiazem Postinfarction Trial Research Group.
Benhorin J; Moss AJ; Oakes D
J Am Coll Cardiol; 1990 Feb; 15(2):253-8. PubMed ID: 2299062
[TBL] [Abstract][Full Text] [Related]
8. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.
Circulation; 1994 Apr; 89(4):1545-56. PubMed ID: 8149520
[TBL] [Abstract][Full Text] [Related]
9. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.
Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators
N Engl J Med; 1997 Jun; 336(23):1621-8. PubMed ID: 9173270
[TBL] [Abstract][Full Text] [Related]
10. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail.
Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe J; Hartzler GO; Overlie P; Donohue B; Chelliah N
J Am Coll Cardiol; 1995 Feb; 25(2):370-7. PubMed ID: 7829790
[TBL] [Abstract][Full Text] [Related]
11. Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial.
Stone SG; Serrao GW; Mehran R; Tomey MI; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Brener SJ; Dangas G; Stone GW
Circ Cardiovasc Interv; 2014 Aug; 7(4):543-51. PubMed ID: 24939928
[TBL] [Abstract][Full Text] [Related]
12. Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction. SPRINT Study Group.
Kornowski R; Goldbourt U; Zion M; Mandelzweig L; Kaplinsky E; Levo Y; Behar S
Am J Cardiol; 1993 Oct; 72(12):883-8. PubMed ID: 8213543
[TBL] [Abstract][Full Text] [Related]
13. Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II.
Berger PB; Ruocco NA; Ryan TJ; Frederick MM; Jacobs AK; Faxon DP
J Am Coll Cardiol; 1992 Sep; 20(3):533-40. PubMed ID: 1512330
[TBL] [Abstract][Full Text] [Related]
14. Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II Study. TIMI II Investigators.
Aguirre FV; McMahon RP; Mueller H; Kleiman NS; Kern MJ; Desvigne-Nickens P; Hamilton WP; Chaitman BR
Circulation; 1994 Jul; 90(1):78-86. PubMed ID: 8026055
[TBL] [Abstract][Full Text] [Related]
15. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II.
Mueller HS; Cohen LS; Braunwald E; Forman S; Feit F; Ross A; Schweiger M; Cabin H; Davison R; Miller D
Circulation; 1992 Apr; 85(4):1254-64. PubMed ID: 1555269
[TBL] [Abstract][Full Text] [Related]
16. Coronary artery bypass graft surgery after thrombolytic therapy in the Thrombolysis in Myocardial Infarction Trial, Phase II (TIMI II).
Gersh BJ; Chesebro JH; Braunwald E; Lambrew C; Passamani E; Solomon RE; Ross AM; Ross R; Terrin ML; Knatterud GL
J Am Coll Cardiol; 1995 Feb; 25(2):395-402. PubMed ID: 7829793
[TBL] [Abstract][Full Text] [Related]
17. Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial.
Terrin ML; Williams DO; Kleiman NS; Willerson J; Mueller HS; Desvigne-Nickens P; Forman SA; Knatterud GL; Braunwald E
J Am Coll Cardiol; 1993 Dec; 22(7):1763-72. PubMed ID: 8245326
[TBL] [Abstract][Full Text] [Related]
18. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
Cannon CP; McCabe CH; Henry TD; Schweiger MJ; Gibson RS; Mueller HS; Becker RC; Kleiman NS; Haugland JM; Anderson JL
J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799
[TBL] [Abstract][Full Text] [Related]
19. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD
J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104
[TBL] [Abstract][Full Text] [Related]
20. Stress echocardiographic results predict risk of reinfarction early after uncomplicated acute myocardial infarction: large-scale multicenter study. Echo Persantine International Cooperative (EPIC) Study Group.
Picano E; Pingitore A; Sicari R; Minardi G; Gandolfo N; Seveso G; Chiarella F; Bolognese L; Chiaranda G; Sclavo MG
J Am Coll Cardiol; 1995 Oct; 26(4):908-13. PubMed ID: 7560616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
